Iatrogenic Cushing’s Syndrome Following Intra-Articular Triamcinolone Injection in an HIV-Infected Patient on Cobicistat Presenting as a Pulmonary Embolism: Case Report and Literature Review

References

• Quddusi S, Browne P, Toivola B, et al. Cushing syndrome due to surreptitious glucocorticoid administration. Arch Intern Med. 1998;158(3):294.
   Google Scholar
• Weber SL. Cushing’S syndrome attributable to topical use of lotrisone. Endocrine Pract. 1997. www.ncbi.nlm.nih.gov/pubmed/15251475.
   Google Scholar
• Nutting CM, Page SR. Iatrogenic Cushing’s syndrome due to nasal betamethasone: a problem not to be sniffed at! Postgrad Med J. 1995;71(834):231–232. doi:10.1136/pgmj.71.834.231
   Web of Science ®Google Scholar
• Hughes JM, Hichens M, Booze GW, Thorner MO. Cushing’s syndrome from the therapeutic use of intramuscular dexamethasone acetate. Arch Int Med. 1986;146(9):1848.
   Google Scholar
• Mann M, Koller E, Murgo A, et al. Glucocorticoid-like activity of megestrol. a summary of food and drug administration experience and a review of the literature. Arch Intern Med. 157(15):1651–6.
   Google Scholar
• Marzolini C, Gibbons S, Khoo S, et al. Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medications. J Antimicrob Chemother. 2016;71(7):1755–1758. doi:10.1093/jac/dkw032
   PubMed Web of Science ®Google Scholar
• Sadarangani S, Berg ML, Mauck W, et al. Iatrogenic cushing syndrome secondary to ritonavir-epidural triamcinolone interaction: an illustrative case and review. Interdiscip Perspect Infect Dis. 2014;2014:849432. doi:10.1155/2014/849432
   PubMedGoogle Scholar
• Yombi JC, et al. Iatrogenic Cushing’s syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir. Clin Rheumatol. 2008. www.ncbi.nlm.nih.gov/pubmed/18827959.
   Google Scholar
• Song Y, Schroeder JR, Bush LM, et al. Iatrogenic cushing syndrome and secondary adrenal insufficiency related to concomitant triamcinolone and ritonavir administration: a case report and review. J Int Assoc Prov AIDS Care. 2014;13(6):511–514.
   Google Scholar
• Foisy MM, Yakiwchuk E, Chiu I, et al. Adrenal suppression and cushing’s syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med. 2008;9(6):389–396.
   PubMed Web of Science ®Google Scholar
• Maviki M, Cowley P, Marmery H, et al. Injecting epidural and intra-articular triamcinolone in HIV-positive patients on ritonavir: beware of iatrogenic Cushing’s syndrome. Skeletal Radiol. 2013;42(2):313–315. doi:10.1007/s00256-012-1539-6
   Web of Science ®Google Scholar
• Molloy A, Matheson NJ, Meyer PA, et al. Cushing’s syndrome and adrenal axis suppression in a patient treated with ritonavir and corticosteroid eye drops. AIDS (London, England). 2011;25(10):1337–1339.
   PubMed Web of Science ®Google Scholar
• Sahıp B, Celik M, Ayturk S, et al. Iatrogenic cushing’s syndrome after topical steroid therapy for psoriasis. Indian J Dermatol. 2016;61(1):120. doi:10.4103/0019-5154.174094
   Web of Science ®Google Scholar
• Dubrocq G, Estrada A, Kelly S, et al. Acute development of Cushing syndrome in an HIV-infected child on atazanavir/ritonavir based antiretroviral therapy. Endocrinol Diabetes Metabol Case Rep. 2017;2017:17–0076. doi:10.1530/EDM-17-0076
   Google Scholar
• Yeoh SW. Iatrogenic cushing syndrome from interaction between ritonavir and oral budesonide during direct acting antiviral Hepatitis C therapy. J Clin Exp Hepatol. 2016;6(3):246–249. doi:10.1016/j.jceh.2016.05.006
   Google Scholar
• Monge E, et al. Iatrogenic Cushing syndrome due to drug interaction between inhaled fluticasone and cobicistat. Le infezioni in medicina. 2019;27(4):445–448.
   Google Scholar
• Wassner C, Maiti S, Kodroff K, et al. “IATROGENIC Adrenal Insufficiency Secondary to Combination Therapy with Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine and Interlaminar Triamcinolone Injection in an AIDS Patient. J Int Assoc Prov AIDS Care. 2017;16(6):535–539.
   PubMedGoogle Scholar
• John G, Ollo D, Meyer P, et al. Pulmonary embolism and iatrogenic Cushing’s syndrome after co-administration of injected-triamcinolone and ritonavir. AIDS (London, England). 2013;27(17):2827–2828. doi:10.1097/QAD.0000000000000010
   Web of Science ®Google Scholar
• A V R. Inhalational Steroids and Iatrogenic Cushing’s Syndrome. Open Respir Med J. 2014;8(1):74–84. doi:10.2174/1874306401408010074
   Google Scholar
• Hall JJ, Hughes CA, Foisy MM, et al. Iatrogenic cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir-boosted darunavir. Int J STD AIDS. 2013;24(9):748–752.
   Web of Science ®Google Scholar
• Elliot ER, Theodoraki A, Jain LR, et al. Iatrogenic Cushing’s syndrome due to drug interaction between glucocorticoids and the ritonavir or cobicistat containing HIV therapies. Clin Med. 2016;16(5):412–418. doi:10.7861/clinmedicine.16-5-412
   PubMed Web of Science ®Google Scholar
• Colpitts L, Murray TB, Tahhan SG, et al. Iatrogenic cushing syndrome in a 47-year-old HIV-positive woman on ritonavir and inhaled budesonide. J Int Assoc Prov AIDS Care. 2017;16(6):531–534.
   Google Scholar
• Blondin M-C, Beauregard H, Serri O, et al. Iatrogenic cushing syndrome in patients receiving inhaled budesonide and itraconazole or ritonavir: two cases and literature review. Endocrine Pract. 2013;19(6):e138–e141.
   Web of Science ®Google Scholar
• Yoganathan K, David L, Williams C, et al. Cushing’s syndrome with adrenal suppression induced by inhaled budesonide due to a ritonavir drug interaction in a woman with HIV infection. Int J STD AIDS. 2012;23(7):520–521.
   PubMed Web of Science ®Google Scholar
• Frankel JK, Packer CD, Cushing’s syndrome due to antiretroviral-budesonide interaction. Ann Pharmacother. 2011;45(6):823–824. doi:10.1345/aph.1P731
   PubMed Web of Science ®Google Scholar
• McConkey HZR, Williams H, Kulasegaram R, et al. Orbital floor triamcinolone causing Cushing’s syndrome in a patient treated with Kaletra for HIV 1. BMJ Case Rep. 2013;2013(feb25 1):bcr0220125849. doi:10.1136/bcr.02.2012.5849
   Google Scholar
• Gray D, Roux P, Carrihill M, et al. Adrenal suppression and Cushing’s syndrome secondary to ritonavir and budesonide. S Afr Med J. 2010;100(5):296–297. doi:10.7196/samj.3848
   PubMed Web of Science ®Google Scholar
• Kedem E, Shahar E, Hassoun G, et al. Iatrogenic Cushing’s syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient. J Asthma. 2010;47(7):830–831. doi:10.3109/02770903.2010.485666
   PubMed Web of Science ®Google Scholar